...
首页> 外文期刊>Cytometry: The Journal of the Society for Analytical Cytology >ELEVATED RELATIVE FLUORESCENCE INTENSITY OF CD38 ANTIGEN EXPRESSION ON CD8(+) T CELLS IS A MARKER OF POOR PROGNOSIS IN HIV INFECTION - RESULTS OF 6 YEARS OF FOLLOW-UP
【24h】

ELEVATED RELATIVE FLUORESCENCE INTENSITY OF CD38 ANTIGEN EXPRESSION ON CD8(+) T CELLS IS A MARKER OF POOR PROGNOSIS IN HIV INFECTION - RESULTS OF 6 YEARS OF FOLLOW-UP

机译:CD8(+)T细胞表达CD38抗原的相对荧光强度升高,预示HIV感染预后不良-随访6年的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Relative fluorescence intensity measurements from a flow cytometer were used to evaluate expression of CD38 and HLA-DR antigens. These molecules are associated with cellular activation and are present at increased levels on the CD8(+) lymphocytes of HIV-infected subjects, In the current study, the prognostic value of mean fluorescence intensity measurements of CD38 and HLA-DR on CD8(+) cells was compared to results from our previous study in which we reported prognostic value for an elevated percentage of CD8(+) cells that were positive for expression of the CD38 antigen (Giorgi et al.: JAIDS 6:904-912, 1993), Using the proportional hazards model, elevated mean fluorescence intensity of CD38 expression on 888 cells had prognostic value for development of AIDS that was almost identical to the prognostic value of the percentage of CD8(+) cells that were positive for expression of CD38. This prognostic value was in addition to that provided by the patient's CD4(+) cell measurement, To our knowledge, this is the first report that a measurement of fluorescence intensity can be used as a prognostic marker in an immunodeficiency disease. Efforts are needed to establish methods that will allow widespread application of this observation in the clinical management of HIV-infected subjects. (C) 1996 Wiley-Liss, Inc. [References: 31]
机译:来自流式细胞仪的相对荧光强度测量被用于评估CD38和HLA-DR抗原的表达。这些分子与细胞活化有关,并以较高的水平存在于HIV感染者的CD8(+)淋巴细胞上。在当前研究中,CD38和HLA-DR对CD8(+)的平均荧光强度测量的预后价值将细胞与我们以前的研究结果进行比较,在该研究中我们报道了CD8(+)细胞表达CD38抗原阳性的预后价值(Giorgi等:JAIDS 6:904-912,1993),使用比例风险模型,在888个细胞上CD38表达的平均荧光强度升高对艾滋病的发展具有预后价值,与对CD38表达呈阳性的CD8(+)细胞百分比的预后价值几乎相同。该预后值是患者CD4(+)细胞测量所提供的预后值。据我们所知,这是首次报道荧光强度的测量可用作免疫缺陷疾病的预后标志物。需要努力建立将这种观察方法广泛应用于HIV感染者临床管理的方法。 (C)1996 Wiley-Liss,Inc. [参考:31]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号